GI and immunosuppressant drug markets set to rocket

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.509, 2006-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug markets and distribution systems

By May Tiggey Hough Mike

Addiction Research and Theory, Vol. 12, Iss. 6, 2004-12 ,pp. : 549-563

Informa Healthcare

Access to resources Recommend Favorite

The influence of in-vivo carbonation on GI physiological processes and drug permeability

By Eichman J.D. Yassin A.E.-D.B. Robinson J.R.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 44, Iss. 1, 1997-07 ,pp. : 33-38

Elsevier

Access to resources Recommend Favorite

New Molecules as Drug Candidates for the Treatment of Upper and Lower GI Tract Ulcers

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 2993-3001

Bentham Science Publishers

Access to resources Recommend Favorite

Markets for metabolic disorders, botulinum toxins set to soar

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 403, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Anxiolytic, atrial fibrillation markets set to expand

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 386, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite